跳至主要内容
临床试验/NCT02164448
NCT02164448已完成4 期

The Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy

Yonsei University1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
92
试验地点
1
主要终点
gas passing

研究概览

简要总结

The investigators hypothesized that sympatholytic effect of dexmedetomidine would attenuate the hemodynamic instability and decrease in the splanchnic blood flow caused by pneumoperitoneum during laparoscopic surgery. This study is to investigate the effect of intraoperative dexmedetomidine infusion on postoperative bowel movement in patients undergoing laparoscopic gastrectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ
  • gastric cancer patient undergoing laparoscopic gastrectomy

排除标准

  • ASA physical status Ⅳ
  • bradycardia (< 60 bpm), arrhythmia
  • uncompensated heart failure
  • hepatic failure (Child-Pugh score B 이상)
  • renal failure (eGFR MDRD < 60 ml/min/1.73m2)

研究组 & 干预措施

dexmedetomidine group

Experimental

干预措施: the dexmedetomidine group (Drug)

control group

Placebo Comparator

干预措施: the control group (Drug)

结局指标

主要结局

gas passing

时间窗: up to 1 week

To evaluate the postoperative bowel movement, we will assess the time to first gas passing

次要结局

  • sips of water time(up to 1 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验